121 results
8-K
EX-99.1
4c7dqwbd0o
25 Mar 24
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
4:05pm
8-K
EX-10.1
0imo168yfcua64
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
424B7
g72bmiz44un
15 Mar 24
Prospectus with selling stockholder info
3:53pm
8-K
EX-4.1
y6klucha 3yj7ma4
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
424B3
ow7t0ma9t m5
15 Dec 22
Prospectus supplement
5:12pm